For rheumatic mitral stenosis, percutaneous balloon
|
|
- Nicholas Hodge
- 6 years ago
- Views:
Transcription
1 CARDIOVASCULAR Consequence of Atrial Fibrillation and the Risk of Embolism After Percutaneous Mitral Commissurotomy: The Necessity of the Maze Procedure Hiroyuki Nakajima, MD, Junjiro Kobayashi, MD, Ko Bando, MD, Yoshio Yasumura, MD, Satoshi Nakatani, MD, Kohji Kimura, MD, Kazuo Niwaya, MD, Osamu Tagusari, MD, and Soichiro Kitamura, MD Department of Cardiovascular Surgery, National Cardiovascular Center, Osaka, Japan Background. We sought to investigate the incidence and risk of embolism after percutaneous balloon mitral commissurotomy (PMC) and delineated the necessity of the maze procedure in patients with atrial fibrillation (AF). Methods. Clinical records of 326 patients, who underwent PMC between April 1988 and March 2003, and 162 patients, who underwent mitral valve surgery (MVS) combined with the maze procedure (MVS/maze) in the same period, were reviewed. We examined the consequence of cardiac rhythm and the incidence and risk of embolism after PMC. Next our current criteria for indication of the maze procedure, which included duration of AF less than 10 years, voltage of f wave on electrocardiography greater than 0.1 mv, cardiothoracic ratio less than 70%, and left atrial dimension less than 70 mm, were applied to all patients. These criteria were satisfied by 190 patients of PMC (PMC group) and 114 patients of MVS/maze (MVS/maze group) and the early and late results of the two groups were compared. Results. Thirty-eight patients suffered from embolic complications after PMC. Of these 33 patients experienced AF before intervention. The actuarial embolismfree rate at 10 years was 81.9% in patients with AF before PMC and 92.9% in patients with sinus rhythm before PMC (p 0.01). Univariate predictors of embolism after PMC included previous embolic history (p 0.01), AF (p 0.01), pressure gradient (p 0.01), age (p 0.03), and mitral valve area (p 0.04). Multivariate analysis identified AF as the independent predictor of embolism in the late follow-up period (p 0.03). In a comparative study of the selected patients the actuarial AF-free rates after MVS/maze were 89.9% at 1 year and 85.7% at 5 years and were significantly higher than those of 17.3% at 1 year and 4.2% at 5 years after PMC (p < ). The actuarial embolism-free rate in the MVS/maze group was 98.0% at 5 years and was significantly higher than that of 84.8% at 5 years and 82.4% at 10 years in the PMC group (p 0.01). Conclusions. PMC alone is not sufficient with regard to sinus rhythm recovery and prevention of embolism. Surgical treatment concomitant with the maze procedure may be beneficial for patients with AF. (Ann Thorac Surg 2004;78:800 6) 2004 by The Society of Thoracic Surgeons For rheumatic mitral stenosis, percutaneous balloon mitral commissurotomy (PMC) is now considered as the first line of therapy for asymptomatic and symptomatic patients [1]. The valve morphology is considered as the most important predictive factor of the immediate and long-term outcomes after PMC. Several prospective studies demonstrated that the efficacy of PMC was comparable with surgical commissurotomy in terms of improvement and its durability of the valve function with less procedural risk [2]. Atrial fibrillation (AF) is a common cardiac arrhythmia in rheumatic valvular disease. Initiation of AF may be closely related to the symptoms caused by a decrease of Accepted for publication April 1, Address reprint requests to Dr Nakajima, Department of Cardiovascular Surgery, National Cardiovascular Center, Fujishirodai, Suita, Osaka , Japan; hnakajim@hsp.ncvc.go.jp. the cardiac output, elevation of the atrial pressure, and increase of the heart rate. AF is also closely associated with thrombus formation in the atrium and systemic arterial embolism. Long-term follow-up studies demonstrated that the development of AF markedly increased the risk of cardiovascular complications. Moreover it is generally accepted that AF concomitant with rheumatic valve disease exhibits a considerably higher relative risk of stroke than AF without valvular disease [3 5]. However the investigation about the effect of PMC on the cardiac rhythm and the incidence and risk of thromboembolic complications after PMC are not conclusive. In open-heart surgery AF and mitral valve disease can be treated simultaneously by performing the maze procedure. The maze procedure is reportedly effective for the prevention of thromboembolic events by elimination of AF [6]. In the last decade the technique of the maze 2004 by The Society of Thoracic Surgeons /04/$30.00 Published by Elsevier Inc doi: /j.athoracsur
2 Ann Thorac Surg NAKAJIMA ET AL 2004;78:800 6 PMC VERSUS MVS/MAZE IN MITRAL STENOSIS AND AF Table 1. Characteristics of Patients Undergoing PMC Total SR AF p Value No. of patients (26%) 242 (74%) Male 93 (29%) 16 (19%) 77 (32%) 0.02 Age at intervention NYHA class History of embolism 61 (5%) 4 (5%) 57 (24%) Surgical commissurotomy 10 (3%) 2 (2%) 8 (3%) 0.5 Mitral valve Orifice area (cm 2 ) Regurgitation 2 55 (17%) 6 (7%) 49 (20%) Mean PG (mm Hg) Tricuspid regurgitation 3 31 (10%) 4 (5%) 27 (11%) 0.06 Dimension of left atrium Follow-up period (mean SD) CARDIOVASCULAR NYHA New York Heart Association; PG pressure gradient; PMC percutaneous balloon mitral commissurotomy; SR sinus rhythm. procedure was modified with the use of ablation devices allowing it to be less invasive [7, 8]. In the present study we assessed the early and late results after PMC to delineate the incidence and predictive factors of embolic complication. Moreover we examined the efficacy of simultaneous treatment for mitral stenosis and AF in terms of thromboembolism prevention by comparing the results of PMC with those of mitral valve surgery combined with the maze procedure (MVS/maze). Material and Methods At the National Cardiovascular Center (Osaka, Japan) between April 1988 and March 2003, 326 patients who underwent PMC to treat severe mitral stenosis and 162 patients who underwent MVS/maze for the simultaneous treatment of mitral stenosis and AF were included in this study. Two-dimensional echocardiography and Doppler study were performed before and after the procedures. The clinical and echocardiographic data of 488 patients that were prospectively collected were reviewed. At first we analyzed the data to determine the incidence and risk of embolic complications after PMC. The patients profiles are summarized in Table 1. The mean age at intervention was 53 9 years. Most candidates of PMC were symptomatic: 232 patients (71.1%) were designated as New York Heart Association (NYHA) functional class II and 23 patients (7.1%) were designated as class III or IV. Upon admission 84 (25.8%) patients exhibited sinus rhythm, whereas 242 patients (74.2%) exhibited AF. PMC Management and Procedure At our institution PMC was initially considered as the treatment for rheumatic mitral stenosis. PMC was indicated mostly for symptomatic patients who did not exhibit moderate mitral regurgitation and extensive calcification. When the thrombus in the left atrium was detected by transesophageal echocardiography before PMC, it was repeatedly assessed after warfarin therapy for several weeks. In the event that the left atrial thrombus was intractable, surgical treatment was chosen. PMC was performed by the transvenous approach. An Inoue balloon was transseptally inserted into the left ventricle using the Brockenbrough technique. During the procedure transesophageal echocardiography was routinely monitored for guidance of the catheter delivery and assessment of the left atrial thrombus, commissural splitting, and changes of mitral valve function. The size of the balloon was determined by the valve orifice area before intervention. Comparative Study of Selected Patients Next we examined the efficacy of simultaneous treatment for mitral stenosis and AF using the comparative study of selected patients. We have established and have been applying the patients selection criteria for the maze procedure since 1998 [9]. The patients who satisfied all the new criteria, which included voltage of f-wave in V1 lead greater than 0.1 mv, cardiothoracic ratio less than 70%, left atrial dimension in systole less than 70 mm, and prior duration of AF less than 10 years, were expected to be highly successful regarding sinus rhythm recovery after the maze procedure. In the present study these criteria were applied to all patients with AF. Onehundred ninety-nine patients (PMC group) who underwent PMC, and 114 patients (MVS/maze group) who underwent MVS/maze were selected. The profiles of the selected patients in both groups are indicated in Table 2. There were significant differences regarding the age at procedure (p ), duration of AF (p ), mitral valve area (p 0.01), the presence of moderate mitral regurgitation (p ), and the dimension of the left atrium (p ) between the two groups. Surgical Procedure Through a standard left atriotomy cardiopulmonary bypass commenced with ascending aortic cannulation and bicaval drainage approaching the mitral valve via the right-sided left atriotomy in all patients. Open mitral commissurotomy was performed in 14 patients (12.3%)
3 CARDIOVASCULAR 802 NAKAJIMA ET AL Ann Thorac Surg PMC VERSUS MVS/MAZE IN MITRAL STENOSIS AND AF 2004;78:800 6 Table 2. Characteristics of Selected Patients PMC MVS/maze p Value No. of selected patients Age at procedure History of embolism 40 (20%) 18 (16%) 0.21 Coronary artery disease 1 (0.5%) 2 (2%) 0.30 NYHA class Duration of AF (yrs) Amplitude of f wave (mv) Cardiothoracic ratio (%) Dimension of LA (mm) Tricuspid regurgitation Mitral valve area (cm 2 ) Mitral regurgitation 2 43 (22%) 60 (53%) Mean PG (mm Hg) History of LA thrombus 3 (2%) 16 (14%) AF atrial fibrillation; LA left atrium; MVS/maze mitral valve surgery combined with the maze procedure; NYHA New York Heart Association; PG pressure gradient; PMC percutaneous balloon mitral commissurotomy. and a prosthetic valve was implanted in 100 patients (87.7%) (mechanical:bioprosthesis 98:2). The diagnosis of rheumatic mitral disease was confirmed by the histologic examination in all patients who underwent valve replacement. The details of the configuration of cryoablation and cut-and-sew lesions in the maze procedure were described previously [7]. Although entire pulmonary venous isolation was achieved by the cut-and-saw technique between May 1992 and August 1998, since September 1998 we have introduced the cryo-maze procedure, which consists of using cryoablation around the pulmonary veins to decrease perioperative complications. Administration of Anticoagulation and Antiarrhythmic Drugs Electrocardiography was continuously monitored after PMC and MVS/maze until the cardiac rhythm became stable. Immediately after the PMC procedure, cardioversion was usually performed in patients with AF. When AF was sustained despite administration of group Ia or Ic antiarrhythmic drugs, cardioversion was performed and done so before discharge. Irrespective of the cardiac rhythm, digoxin or verapamil were used to control heart rate. The antiarrhythmic drugs were withdrawn when the cardiac rhythm stabilized, which typically occurred 3 months after the procedure was performed (PMC or maze). Warfarin was routinely administered to patients who exhibited AF or had mechanical valves. Prothrombin time was usually monitored every month. The target range was between 1.8 and 2.8 of the international normalized ratio. Follow-Up Patients were followed-up with periodical electrocardiography, chest roentgenography, and echocardiography. Data was collected from the clinical records and by Table 3. Early and Late Results of PMC Events SR n 84 AF n 242 p Value Early results ( ); mortality Embolism 0 4 (0) 0.30 Mitral valve surgery 0 1 (0) 0.74 Endocarditis 0 1 (0) 0.74 Late results ( ); mortality Embolism 5 (0) 33 (5) 0.04 stroke peripheral embolism Bleeding 0 2 (0) 0.55 Mitral valve surgery 65 (0) 196 (2) 0.81 Endocarditis 1 (0) 3 (0) 0.73 Others 0 9 (9)... AF atrial fibrillation; PMC percutaneous balloon mitral commissurotomy; SR sinus rhythm. correspondence with physicians who applied these guidelines to patients after valvular operation, PMC, and MVS/maze. Embolism included stroke that was defined as a neurologic deficit concomitant with ischemic findings on computed tomography and/or magnetic resonance imaging and transient ischemia due to cardiogenic embolism certainly diagnosed by a neurologist, and peripheral thromboembolism. Permanent and transient ischemia related to atherosclerotic disease were not included as endpoints of this study. Follow-up was performed by the outpatient clinic and biannual mail interview. The mean follow-up period was months in patients post-mvs/maze and months in those post-pmc (p ). Statistical Analysis The continuous variables are expressed as the mean values SD. The Kaplan Meier method was used to determine the actuarial embolism-free and AF-free rates. Cox regression analysis was used to examine the significance of the clinical and echocardiographic variables for predicting the embolism-free time. The clinical and echocardiographic data of the two groups were compared using Fisher s exact test or Wilcoxon s log-rank sum test. The differences were considered statistically significant at p less than Results Early and Late Outcome of PMC Early and late complications post-pmc are listed in Table 3. During the follow-up period 38 patients experienced an embolic complication. Of these, 33 patients exhibited AF and 5 patients exhibited sinus rhythm before intervention. In addition the second embolic attack occurred in 6 patients. The actuarial AF-free rates were 15.0% at 1 year and 3.4% at 5 years in patients with AF before PMC and were 93.5% at 1 year and 75.6% at 5 years in patients with sinus rhythm before PMC (p ). The actuarial embolism-free rates in patients with sinus rhythm before
4 Ann Thorac Surg NAKAJIMA ET AL 2004;78:800 6 PMC VERSUS MVS/MAZE IN MITRAL STENOSIS AND AF Table 5. Early and Late Results in Selected Patients PMC n 199 MVS/maze n p Value CARDIOVASCULAR Fig 1. The actuarial embolism-free rate after percutaneous balloon mitral commissurotomy. AF atrial fibrillation; SR sinus rhythm. PMC were 97.3% at 5 years and 92.9% at 10 years and in patients with AF before PMC the rates were 85.7% at 5 years and 81.9% at 10 years, which is significantly lower (p 0.01) (Fig 1). The univariate predictors of embolism after PMC included age (p 0.03), history of embolism (p 0.01), AF (p 0.01), mitral valve area (p 0.04), and pressure gradient (p 0.01). Multivariate analysis identified AF as the independent predictor of embolism in the late follow-up period (p 0.03) (Table 4). Comparative Study for Selected Patients The early and late complications are summarized in Table 5. The early mortality rate of MVS/maze was 0.9% in the selected patients. One patient who underwent the conventional maze procedure suffered from myocardial infarction and expired. In late results embolism occurred in 25 patients after PMC and in 2 patients after MVS/ maze (p ). There was no significant difference in the incidence of anticoagulant-related bleeding between the groups (p 0.74). The actuarial AF-free rates after MVS/maze were 89.9% at 1 year and 85.7% at 5 years and were significantly higher than those of 17.3% at 1 year and 4.2% at 5 years after PMC (p ) (Fig 2). The actuarial embolism-free rates were 98.0% at 5 years and 10 years after MVS/maze as compared with 84.8% at 5 years and 82.4% at 10 years after PMC (p 0.01) (Fig 3). The Early results Mortality Operative death ( 30 days) Hospital death ( 30 days) 0 1* (0.9%) 0.36 Morbidity ( 30 days) Embolism (stroke) 2 (1.0%) Mitral valve surgery 1 (0.5%) Mediastinitis 0 2 (1.9%) 0.13 Late results ( ); mortality Embolism 25 (4) 2 (0) Bleeding 3 (0) 2 (1) 0.74 Mitral valve surgery 38 (2) 4 (0) Endocarditis 3 (0) Others 6 (6) 1 (1)... MVS/maze mitral valve surgery combined with the maze procedure; PMC percutaneous balloon mitral commissurotomy. actuarial embolism-free survival rate in the MVS/maze group was 95.5% at 5 years and 91.3% at 10 years and was significantly higher that that of 85.3% at 5 years and 79.3% at 10 years in the MVS/maze group (p 0.04). Comment As valvular fibrosis and calcification progresses, AF usually occurs in patients with rheumatic heart disease. In fact about 40% 75% of the patients with mitral stenosis exhibit concomitant AF at the time of intervention [10 13]. It was reported that there was a clear correlation between the development of mitral stenosis and the initiation of AF [14] and that AF closely correlated with the initiation of symptoms caused by a loss of atrial contraction and tachycardia. In addition the risk of the associated embolic complications is considerably high because of increased platelet function, coagulation status, and dilated atrium [3 5]. Therefore thromboembolism can occur as the initial event in some patients with mitral stenosis and AF. The administration of anticoagulants is feasible but not sufficient for the prevention of a stroke [14, 15]. Consequently AF has been accepted as an independent risk factor for morbidity and mortality [3]. Regarding the initiation of AF it had been previously Table 4. Cox Regression Analysis of Predictors of Embolism After PMC Variables Univariate Multivariate Hazard Ratio (95% CI) p Value Hazard Ratio (95% CI) p Value Age (yrs) 1.40 ( ) ( ) 0.5 History of embolism 2.33 ( ) ( ) 0.67 Atrial fibrillation 3.11 ( ) ( ) 0.03 Mitral valve area (cm 2 ) 3.26 ( ) ( ) 0.08 Pressure gradient (mm Hg) 0.99 ( ) ( ) 0.09 Dimension of LA (mm) 1.01 ( ) ( ) 0.39 CI confidence interval; LA left atrium; PMC percutaneous balloon mitral commissurotomy.
5 CARDIOVASCULAR 804 NAKAJIMA ET AL Ann Thorac Surg PMC VERSUS MVS/MAZE IN MITRAL STENOSIS AND AF 2004;78:800 6 Fig 2. The actuarial atrial fibrillation free rate in selected patients. (MVS/maze mitral valve surgery combined with the maze procedure; PMC percutaneous balloon mitral commissurotomy.) believed that AF was primarily related to the elevation of left atrial pressure and enlargement of the left atrium. However recent investigations have proposed that the presence of ectopic foci in pulmonary veins is the trigger initiating AF [16]. The dilated left atrium, degeneration of the left atrial myocardium caused by rheumatic inflammation, and the elevated atrial pressure also contribute to perpetuation of AF. Additionally the persistence of AF induces some structural and electrophysiological remodeling in the atrial myocardium [17]. Therefore it has been considered that recovery of valve function alone is not sufficient for sinus rhythm recovery [18]. PMC provides a hemodynamic improvement via enlargement of the valve orifice and is regarded as an effective and less invasive alternative to surgical commissurotomy. PMC is widely applicable for various patients including the young, aged, pregnant, and those unsuitable for surgery [19]. Several randomized studies demonstrated that the improvement and durability of the valve orifice area after PMC are similar to those after conventional surgical commissurotomy [3]. The morphology of the mitral valvular structure is considered as one of the most important predictive factors of successful Fig 3. The actuarial embolism-free rate in selected patients. (MVS/ maze mitral valve surgery combined with the maze procedure; PMC percutaneous balloon mitral commissurotomy.) PMC. Echocardiographic assessment has been widely used [10, 20, 21]. In addition the age [20, 22], NYHA functional class [10, 20], and anatomical form [22] are also long-term predictive factors regarding survival rate and repeated intervention. Concerning the freedom from valve replacement and survival after PMC the influence of AF is still controversial. Tarka and associates mentioned that although patients with sinus rhythm exhibited a greater cardiac output resulting in a larger final valve area than patients with AF, there was no significant difference in the longterm event-free survival rate between sinus rhythm and AF patients [12, 23]. In contrast there are some reports which state that the presence of AF is an independent or notable predictor of suboptimal early results, repeated intervention, and late mortality after PMC [10, 11, 22]. The investigation about the incidence and risk of embolism after PMC are very few, because embolism was not included among the end points in most of the clinical follow-up studies and prospective randomized studies. Although it has been believed that PMC exhibits favorable effects with regard to the prevention of thrombus formation by suppression of increased coagulability and disappearance of spontaneous echo contrast in the left atrium [4, 5, 13, 22, 24], it may be hypothesized that patients who underwent PMC exhibit a potential risk similar to those who underwent surgical commissurotomy. Hickey and associates reported that the thromboembolism-free rate after surgical commissurotomy was 94% at 5 years and 90% at 10 years, whereas AF was present in 38% of their patients [25]. In a review of the published literature it was noted that Smith and associates reported the incidence of embolism after open and closed valvotomy as % per patient per year in patients with AF, whereas it was reported to be % per patient per year in patients with sinus rhythm [26]. In the present study patients with AF before PMC could not resume sinus rhythm after PMC and the presence of AF before PMC significantly correlated with embolism in the late follow-up period after PMC. The incidence of embolic complication was 2.0% per patient per year in patients with AF before PMC. These results are in agreement with previous reports [25, 26]. In addition the maze procedure was effective and indispensable for sinus rhythm recovery and provided a significantly lower incidence of embolic complications as compared with PMC alone. These results strongly suggest that the presence of AF and the probability of sinus rhythm recovery should be taken into consideration when determining the indication of PMC and surgical treatment with regard to reducing embolic complications in the late follow-up period. The safety of including the maze procedure in the surgical treatment is considered acceptable. One patient died of myocardial infarction in the MVS/maze group, however this occurred before the introduction of our modified maze procedure. Although the cause remains unclear we speculate that it may be related to the operative maneuver of the conventional maze procedure that mainly employed the cut-and-sew technique. Re-
6 Ann Thorac Surg NAKAJIMA ET AL 2004;78:800 6 PMC VERSUS MVS/MAZE IN MITRAL STENOSIS AND AF cently the surgical technique of the maze procedure has been simplified. In our current maze procedure we use cryoablation for isolation of the pulmonary venous orifices instead of the cut-and-sew technique. It provides a sinus rhythm recovery rate comparable with that of the conventional maze procedure with a simple and safe surgical technique [7]. Because this study was retrospective and nonrandomized some differences regarding the characteristics of the PMC and MVS/maze groups were noted. These differences are the limitations of this study, however the influence of these differences on the late results before procedures were performed may not be important. This is because older age, lengthier history of AF, and larger left atriums in the MVS/maze group indicated that the patients in the MVS/maze group exhibited more advanced rheumatic valvular disease. Moreover although patients before MVS/maze commonly exhibited moderate mitral regurgitation, most of them underwent valve replacement and were diagnosed with rheumatic degeneration by the pathologic examination. NYHA class and mean pressure gradient across the mitral valve were similar in both groups. In conclusion because the presence of AF before PMC significantly correlated with thromboembolism in the late follow-up period after PMC, surgical treatment may only be beneficial for the patients who are considered as favorable candidates for the maze procedure. The prolonged duration of AF by deferment of surgical treatment may diminish the opportunity to restore sinus rhythm and lead to increased the risk of embolism. References 1. Iung B, Gohlke-Barwolf C, Tornos P, et al. Working Group on Valvular Heart Disease. Recommendation on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 2002;23: Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994;331: Wolf PA, Dawber TR, Thomas HE, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978;28: Zaki A, Salama M, El Marsy M, et al. Immediate effect of balloon valvuloplasty on hemostatic changes in mitral stenosis. Am J Cardiol 2000;85: Cormier B, Vahanian A, Iung B, et al. Influence of percutaneous mitral commissurotomy on left atrial spontaneous contrast of mitral stenosis. Am J Cardiol 1993;71: Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 1999;118: Nakajima H, Kobayashi J, Bando K, et al. The effect of cryo-maze procedure on early and intermediate term outcome in mitral disease: case matched study. Circulation 2002;106(Suppl I):I Sie HT, Beukema WP, et al. Radiofrequency modified maze 805 in patients with atrial fibrillation undergoing concomitant cardiac surgery. J Thorac Cardiovasc Surg 2001;122: Kobayashi J, Kosakai Y, Nakano K, et al. Improved success rate of the maze procedure in mitral valve disease by new criteria for patients selection. Eur J Cardiothorac Surg 1998;13: Palacios IF, Sanchez PL, Harrell LC, et al. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and post valvuloplasty variables that predict long-term outcome. Circulation 2002;105: Leon MN, Harrel LC, Simosa HF, et al. Mitral balloon valvotomy for patients with mitral stenosis in atrial fibrillation Immediate and long-term results. J Am Coll Cardiol 1999;34: Tarka EA, Blitz LR, Herrmann HC. Homodynamic Effects and long-term outcome of percutaneous balloon valvuloplasty in patients with mitral stenosis and atrial fibrillation. Clin Cardiol 2000;23: Chiang CW, Lo SK, Ko YS, et al. Predictor of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med 1998;128: Horskotte D, Niehues R, Stauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J 1991;12: Stern S, Altkorn D, Levinson W. Anticoagulation for chronic atrial fibrillation. JAMA 2000;283: Haissaguerre M, Jais P, Shan DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary vein. N Engl J Med 1998;339: Kamalvand K, Tan K, Lloyd G, et al. Alteration in atrial electrophysiology associated with chronic atrial fibrillation in man. Eur Heart J 1999;20: Wang A, Pulsipher MW, Harrison JK, et al. Predictors and significance of atrial rhythm before and six months after percutaneous balloon mitral commissurotomy. Am J Cardiol 1999;83: Sutaria N, Elder AT, Shaw TRD. Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over. Heart 2000;83: Dean LS, Mickel M, Bonan R, et al. Four-year follow up of the patients under going percutaneous balloon mitral commissurotomy. A report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. J Am Coll Cardiol 1996;28: Palacios IF, Tuzcu ME, Weyman AE, et al. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation 1995;91: Iung B, Garbarz E, Mauchaud P, et al. Late results of percutaneous mitral commissurotomy in series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation 1999; 99: Iung B, Vahanian A. The long-term outcome of balloon valvuloplasty for mitral stenosis. Curr Cardiol Rep 2002;4: Iung B, Cormier B, Farah B, et al. Percutaneous mitral commissurotomy in the elderly. Eur Heart J 1995;16: Hickey MSJ, Blackstone EH, Kirklin JW, et al. Outcome probabilities and life history after surgical mitral commissurotomy: implications for balloon commissurotomy. J Am Coll Cardiol 1991;17: Smith WM, Neutze JM, Barratt-Boyes BG, et al. Open mitral valvotomy. Effect of the preoperative factors on results. J Thorac Cardiovasc Surg 1981;82: CARDIOVASCULAR INVITED COMMENTARY This study, although limited by its retrospective design, is I believe an important one. The data confirm the excellent results that can be achieved with percutaneous balloon commissurotomy (PBC) with respect to function 2004 by The Society of Thoracic Surgeons /04/$30.00 Published by Elsevier Inc doi: /j.athoracsur
The role of percutaneous mitral balloon valvuloplasty
Which Patients Benefit From Percutaneous Mitral Balloon Valvuloplasty? Prevalvuloplasty and Postvalvuloplasty Variables That Predict Long-Term Outcome Igor F. Palacios, MD; Pedro L. Sanchez, MD; Lari C.
More informationApproximately 40% to 60% of patients who undergo mitral valve
Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease Ko Bando, MD a Junjiro Kobayashi, MD a Yoshio Kosakai, MD b Mitsuhiro Hirata, MD a Yoshikado Sasako,
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationDurability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement
Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Masaki Hamamoto, MD, Ko Bando, MD, Junjiro Kobayashi, MD, Toshihiko Satoh, MD, MPH, Yoshikado
More informationAF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT
AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT 5-2014 Atrial Fibrillation therapeutic Approach Rhythm Control Thromboembolism Prevention: Recommendations Direct-Current
More informationSurgical Ablation of Atrial Fibrillation. Gregory D. Rushing, MD. Assistant Professor, Division of Cardiac Surgery
Surgical Ablation of Atrial Fibrillation Gregory D. Rushing, MD Assistant Professor, Division of Cardiac Surgery Midwestern Conference on Optimizing Electrophysiology Patient Care and Procedural Success
More informationDespite improvements in valve design, stroke remains a serious
Surgery for Acquired Cardiovascular Disease Bando et al Early and late stroke after mitral valve replacement with a mechanical prosthesis: Risk factor analysis of a 24-year experience Ko Bando, MD a Junjiro
More informationBogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010
Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationWhich Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?
Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should
More informationMitral Balloon Valvotomy for Patients With Mitral Stenosis in Atrial Fibrillation Immediate and Long-Term Results
Journal of the American College of Cardiology Vol. 34, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00310-1 Mitral
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationCatheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?
: Another Option for AF Atrial fibrillation (AF) is a highly common cardiac arrhythmia and a major risk factor for stroke. In this article, Dr. Khan and Dr. Skanes detail how catheter ablation significantly
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationClinical Investigations
Clinical Investigations Immediate and Long-term Results Following Balloon Mitral Valvotomy in Patients With Atrial Fibrillation Address for correspondence: Harikrishnan Sivadasan Pillai, MD Department
More informationLong term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over
Heart 2000;83:433 438 433 Department of Cardiology, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK N Sutaria A T Elder T R D Shaw Correspondence to: Dr Shaw Accepted 9 September 1999
More informationClinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationSurgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan
Surgical AF Ablation : Lesion Sets and Energy Sources What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Disclosures Consultant/Advisory Board: Abbott, Edwards Lifesciences
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE
271 NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedures overview of cryoablation for atrial fibrillation as an associated procedure with other cardiac
More informationAtrial fibrillation (AF) is associated with increased morbidity
Ablation of Atrial Fibrillation with Concomitant Surgery Edward G. Soltesz, MD, MPH, and A. Marc Gillinov, MD Atrial fibrillation (AF) is associated with increased morbidity and mortality in coronary artery
More informationMædica - a Journal of Clinical Medicine
MAEDICA a Journal of Clinical Medicine 2013; 8(4): 333-337 Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Percutaneous Transvenous Mitral Commissurotomy in Elderly Mitral Stenosis Patients. A
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationInvasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic
Invasive and Medical Treatments for Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic Disclosures Fellow s advisory panel for St Jude Medical Speaking honoraria from: Boston
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve
More informationNew Guidelines: Surgical Ablation of Atrial Fibrillation. Niv Ad, MD
New Guidelines: Surgical Ablation of Atrial Fibrillation Niv Ad, MD Potential conflicts of interest Niv Ad, MD I have the following potential conflicts of interest to report: Atricure Inc.: Medtronic:
More informationOptions for my no option Patients Treating Heart Conditions Via a Tiny Catheter
Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural
More informationChanges in P-Wave After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis and Left Atrial Enlargement
Article Original Article Changes in P-Wave After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis and Left Atrial Enlargement José Carlos Estival Tarastchuk, Ênio Eduardo Guérios, Sônia
More informationPercutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat
Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,
More informationChapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine
Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the
More informationSURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators ACC Late Breaking Clinical Trials March 16,
More informationClinical material and methods. Fukui Cardiovascular Center, Fukui, Japan
Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui
More information480 April 2004 PACE, Vol. 27
Incremental Value of Isolating the Right Inferior Pulmonary Vein During Pulmonary Vein Isolation Procedures in Patients With Paroxysmal Atrial Fibrillation HAKAN ORAL, AMAN CHUGH, CHRISTOPH SCHARF, BURR
More informationM operations, with closed mitral valvotomy first reported
Comparison of Balloon Valvuloplasty With Operative Treatment for Mitral Stenosis Jeffrey M. Cohen, MHS, Donald D. Glower, MD, J. Kevin Harrison, MD, Thomas M. Bashore, MD, William D. White, MPH, L. Richard
More informationClinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD
Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery WVU Heart and Vascular Institute
More informationAnn Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article
Ann Thorac Cardiovasc Surg 2015; 21: 53 58 Online April 18, 2014 doi: 10.5761/atcs.oa.13-00364 Original Article The Impact of Preoperative and Postoperative Pulmonary Hypertension on Long-Term Surgical
More informationThe Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It. Chandra Kumbar MD FACC FHRS The Heart Group, Evansville IN
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It Chandra Kumbar MD FACC FHRS The Heart Group, Evansville IN Disclosures Consultant Advisory Board, Medtronic Atrial fibrillation
More informationBalloon Dilatation of the Cardiac Valves
2 3 Balloon Dilatation of the Cardiac Valves Igor F. Palacios and Pedro L. Sánchez Percutaneous Pulmonic Valvuloplasty.............. 557 Percutaneous Mitral Balloon Valvotomy for Patients with Rheumatic
More informationImages in Cardiovascular Medicine
Images in Cardiovascular Medicine Management of Severe Mitral Stenosis During Pregnancy Rebecca S. Norrad, MBBS; Omid Salehian, MSc, MD, FRCPC, FACC, FAHA A 37-year-old woman originally from Iraq was referred
More information2018 CODING AND REIMBURSEMENT FOR. Cardiac Surgical Ablation and Left Atrial Appendage Management
2018 CODING AND REIMBURSEMENT FOR Cardiac Surgical Ablation and Left Atrial Appendage Management Introduction This information is shared for educational purposes and current as of January 2018. Healthcare
More informationThe Edge-to-Edge Technique f For Barlow's Disease
The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele
More information13/06/2018. Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment. Mitral Stenosis ESC Guidance 2017
Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment Dave Northridge Edinburgh Heart Centre Rheumatic mitral stenosis Prosthetic mitral dysfunction Calcific/degenerative
More informationClosed mitral valvotomy was first reported by Cutler
Mitral Commissurotomy, a Technique Outdated? Long-Term Follow-up Over a Period of 35 Years Christian Detter, MD, Teddy Fischlein, MD, Christina Feldmeier, MD, Georg Nollert, MD, Hermann Reichenspurner,
More informationDisclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech
Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular
More informationBalloon mitral valvuloplasty
Echo for selecting and monitoring procedures in mitral valve diseases Balloon mitral valvuloplasty Eric Brochet,MD Cardiology Department Hôpital Bichat. Paris France Conflict of interest : none Balloon
More informationAtrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology
Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance
More informationEchocardiographic evaluation of mitral stenosis
Echocardiographic evaluation of mitral stenosis Euroecho 2011 Philippe Unger, MD, FESC Erasme Hospital, ULB, Brussels, Belgium I have nothing to declare EuroHeart Survey Etiology of single native left-sided
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE
266 NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedures overview of microwave ablation for atrial fibrillation as an associated procedure with other
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationTAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?
TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular
More informationA case report: Percutaneous transcatheter treatment of Lutembacher syndrome
A case report: Percutaneous transcatheter treatment of Lutembacher syndrome Dr. Sainath Hegde* Dr. Tukaram Aute** *Registrar, Dept of Cardiology, M.G.M Hospital, Aurangabad. **Asst. Prof, Dept of Cardiology,
More informationAtrial Fibrillation Procedures Data Summary. Participant STS Period Ending 12/31/2016
Period Ending 12/31/2016 Number of Cases Preoperative Predominant Atrial Arrhythmia Type Paroxysmal Atrial Fibrillation... - - Persistent Atrial Fibrillation... - - Longstanding Persistent Atrial Fibrillation...
More informationUSE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS
USE OF BALLOON VALVOTOMY AS BRIDGE TO SURGERY FOR SEVERE HIGH RISK MITRAL STENOSIS Prof. Gerald Yonga MBChB, MMed, MBA, FRCP(Edin),FESC, FACC Aga Khan University Hospital Nairobi, Kenya. RHEUMATIC HEART
More informationThe CHADS Score Role in Managing Anticoagulation After Surgical Ablation for Atrial Fibrillation
The CHADS Score Role in Managing Anticoagulation After Surgical Ablation for Atrial Fibrillation Niv Ad, MD, Linda Henry, PhD, RN, Karen Schlauch, PhD, Sari D. Holmes, PhD, and Sharon Hunt, MBA Inova Heart
More informationThe influence of age on atrial fibrillation recurrence after the maze procedure in patients with giant left atrium
The influence of age on atrial fibrillation recurrence after the maze procedure in patients with giant left atrium Seung Hyun Lee, MD, Joon Bum Kim, MD, Won Chul Cho, MD, Cheol Hyun Chung, MD, Sung Ho
More informationRestoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery
Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery John M. Stulak, MD,* Hartzell V. Schaff, MD, Joseph A. Dearani, MD, Thomas A. Orszulak,
More informationResearch Grant from Servier
Disclosures ESC Paris 2011 Claire Bouleti, MD Research Grant from Servier Long-term impact of repeat Percutaneous Mitral Commissurotomy on the need for surgery in mitral stenosis. Insight from a series
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationTransient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction
Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology
More informationArrhythmia 341. Ahmad Hersi Professor of Cardiology KSU
Arrhythmia 341 Ahmad Hersi Professor of Cardiology KSU Objectives Epidemiology and Mechanisms of AF Evaluation of AF patients Classification of AF Treatment and Risk stratification of AF Identify other
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationValve Disease in the Pregnant Patient
Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If
More informationAF Today: W. For the majority of patients with atrial. are the Options? Chris Case
AF Today: W hat are the Options? Management strategies for patients with atrial fibrillation should depend on the individual patient. Treatment with medications seems adequate for most patients with atrial
More informationPercutaneous Mitral Valve Repair
Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip
More informationIschemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationConcomitant procedures using minimally access
Surgical Technique on Cardiac Surgery Concomitant procedures using minimally access Nelson Santos Paulo Cardiothoracic Surgery, Centro Hospitalar de Vila Nova de Gaia, Oporto, Portugal Correspondence to:
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More informationValvular Heart Disease Mitral Stenosis
Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationFirst Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always
ISPUB.COM The Internet Journal of Cardiology Volume 9 Number 2 First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not T D, J P. Citation T D, J P.. First Transfemoral
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationAlthough mitral valve replacement (MVR) is no longer the surgical
Surgery for Acquired Cardiovascular Disease Ruel et al Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves Marc Ruel, MD, MPH a,b Fraser D.
More informationWhat s New in the Guidelines for Surgical Ablation for Atrial Fibrillation?
What s New in the Guidelines for Surgical Ablation for Atrial Fibrillation? Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery West Virginia University
More informationReally Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?
Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? David H. Adams, MD Cardiac Surgeon-in-Chief Mount Sinai Health System Marie Josée and Henry R. Kravis Professor and
More informationInfluence of Atrial Fibrillation on Outcome Following Mitral Valve Repair
Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationWhen Should I Order a Stress Test or an Echocardiogram
When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular
More informationPage 1. Current Trends in the Management of Atrial Fibrillation: Left Atrial Appendage Occlusion. Atrial fibrillation: Scope of the problem
Current Trends in the Management of Atrial Fibrillation: Left Atrial Appendage Occlusion Benjamin A. D Souza, MD, FACC, FHRS Assistant Professor of Clinical Medicine Penn Presbyterian Medical Center Cardiac
More informationSpecific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
More informationAtrial fibrillation Etiology and complications - A descriptive study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-081.Volume 14, Issue 9 Ver. I (Sep. 2015), PP 115-119 www.iosrjournals.org Atrial fibrillation Etiology and complications
More informationBalloon mitral commissurotomy in juvenile rheumatic mitral stenosis: a ten-year clinical and echocardiographic actuarial results
European Heart Journal (2003) 24, 1349 1356 Balloon mitral commissurotomy in juvenile rheumatic mitral stenosis: a ten-year clinical and echocardiographic actuarial results H. Gamra*, F. Betbout, K. Ben
More information7. Echocardiography Appropriate Use Criteria (by Indication)
Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous mitral valve leaflet repair for mitral regurgitation Mitral regurgitation
More informationStand alone maze: when and how?
Stand alone maze: when and how? Dong Seop Jeong Department of Thoracic and Cardiovascular Surgery, HVSI Samsung Medical Center Type of atrial fibrillation First diagnose AF Paroxysmal AF: self-terminating
More informationIntroducing the COAPT Trial
physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing
More informationManuel Castella MD PhD Hospital Clínic, University of
Manuel Castella MD PhD Hospital Clínic, University of Barcelona mcaste@clinic.ub.es @mcastellamd www.escardio.org/guidelines European Heart Journal - doi:10.1093/eurheartj/ehw210 Providing integrated care
More informationThe Maze III procedure was introduced in 1995 as a
Long-Term Effects of the Maze Procedure on Atrial Size and Mechanical Function Stefan Lönnerholm, MD, Per Blomström, MD, Leif Nilsson, MD, and Carina Blomström-Lundqvist, MD Departments of Cardiology and
More informationΚατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.
Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Rhythm control antiarrhythmic drugs vs catheter ablation Summary
More informationRuolo della ablazione della fibrillazione atriale nello scompenso cardiaco
Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Matteo Anselmino Division of Cardiology Città della Salute e della Scienza Hospital University of Turin, Italy Disclosure: Honoraria
More information